Cerebral to pay nearly $3.7M over controlled substance prescribing practices

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

71% of Consumers Believe Generative AI Can Revolutionize Healthcare

What You Should Know: A recent survey conducted by Deloitte’s Center for Health Solutions (Center) revealed a growing acceptance and optimism among consumers regarding the

November 21, 2023

EyeBio doubles the size of its Series A as anti-VEGF veterans seek new ways of treating retinal diseases

Retinal disease biotech EyeBio has doubled the size of its initial Series A raise from February 2022. With another $65 million, the biotech will further

November 15, 2023

What is the pharmacy of the future? – Pharmaceutical Technology

Image credit: Shutterstock/miguelglxz In the post-Covid-19 era, drug shortages are putting extra strain on pharmacists and patients. Pharmacists are trying to manage stock levels and

October 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.